The Section of Infectious Diseases is actively engaged in research as “old” germs find new ways to fight antimicrobial medicine, “new” germs cause new diseases, established diseases change patterns over time, and new antimicrobial medicines and vaccines are being developed.
Infectious Disease has two clinical trials in the use of intravenous medications for the treatment of severe influenza (flu). Additional areas of interest for future clinical trials and research include influenza, Hepatitis C, MRSA, etc.
Infectious Disease does additional research in other areas too including a follow-up on patients who have experienced Clostridium difficile colitis, more commonly known as C. Diff.; which is a bacterium that can cause symptoms ranging from diarrhea to life-threatening inflammation of the colon.
Additional Infectious Disease research activities include:
- Jayasimha Rao, Ph.D. does work in the laboratory that is heavily engaged in the molecular epidemiology of hospital acquired infections, particularly those due to multi-drug resistant Acinetobacter. Dr. Rao is also pursuing research in the pathogenesis of Pseudomonas infections and gene regulation for which he has recently secured extramural funding.
- Thomas Kerkering, M.D. is studying the epidemiology of Hepatitis C in Southwest Virginia as it relates to the use of intravenous oxycontin and methamphetamines.
- Ryan White programs in the treatment of HIV
- HRSA grant related to the treatment of HIV-HCV co-infected patients
- Since the fall of 2009 Infectious Disease Section members, residents and students have presented 14 Abstracts at the Carilion Clinic Research Day and at various conferences across the state and overseas.
- Several articles published in peer-reviewed journals
If you would like additional information on research going on in Infectious Disease, please contact Dr. Kerkering.